Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease

Respiratory Medicine · Published 2026-07-16 · DOI 10.1016/j.rmed.2026.109040

Authors (4)

Rizwan Qaisar, Imran Ullah Khan, Asima Karim, Firdos Ahmad

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Qaisar, R., Khan, I., Karim, A., et al. (2026). Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2026.109040

Related articles

• Immunosuppressive medication patterns in rheumatoid arthritis–associated interstitial lung disease by antifibrotic documentation status: A multicenter U.S. electronic health record study · Respiratory Medicine · 2026 · Same journal
• Adults with congenital lung malformations: A descriptive analysis of an underexplored population · Respiratory Medicine · 2026 · Same journal
• Use of dual targeting during volume control ventilation is associated with increased delivery of non-lung-protective tidal volumes · Respiratory Medicine · 2026 · Same journal
• Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma · Respiratory Medicine · 2026 · Same journal
• Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience · Respiratory Medicine · 2026 · Same journal
• Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients · Respiratory Medicine · 2026 · Same journal
• Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management · Respiratory Medicine · 2026 · Same journal
• Oxidative Stress–Driven Dysregulation of the MMP-2/TIMP-2 Axis in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Genetic Polymorphisms, and Therapeutic Implications · Respiratory Medicine · 2026 · Same journal
• Smoking cessation and depression risk in newly diagnosed COPD patients: A nationwide cohort study · Respiratory Medicine · 2026 · Same journal
• Changes in peripheral blood leukocyte profiles during elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis according to baseline lung function · Respiratory Medicine · 2026 · Same journal